hereditary ataxia: A hereditary disorder consisting of degeneration of the cerebellum and/or of the spine; most cases feature both to some extent, and therefore present with overlapping cerebellar and sensory ataxia, even though one is often more evident than the other. Hereditary disorders causing ataxia include autosomal dominant ones such as spinocerebellar ataxia, episodic ataxia, and dentatorubropallidoluysian atrophy, as well as autosomal recessive disorders such as Friedreich's ataxia (sensory and cerebellar, with the former predominating) and Niemann Pick disease, ataxia-telangiectasia (sensory and cerebellar, with the latter predominating), and abetalipoproteinaemia. An example of X-linked ataxic condition is the rare fragile X-associated tremor/ataxia syndrome or FXTAS.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
457 |
4. Check minimum number of eventsNone |
457 |
5. Include endpointsNone |
457 |
6. Filter based on genotype QC (FinnGen only) |
457 |
Control definitions (FinnGen only)
- Control exclude
- G6_NEUATR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G10-G13
- Name in latin
- Ataxia hereditaria
Similar endpoints
↥List of similar endpoints to
Hereditary ataxia
based on the number of shared cases.
Similar with more cases:
- Systemic atrophies primarily affecting the central nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4821 | 2073 | 2663 |
| Only index persons | 3377 | 1566 | 1811 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.06 | 0.07 |
| Only index persons | 0.06 | 0.06 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 55.02 | 56.38 | 53.71 |
| Only index persons | 53.07 | 54.05 | 52.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 457 | 197 | 260 |
| Unadjusted period prevalence (%) | 0.09 | 0.07 | 0.11 |
| Median age at first event (years) | 56.48 | 55.24 | 57.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 418
- Matched controls
- 4180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
+∞
234.0
202
*
G11.2
ICD-10 Finland
Late-onset cerebellar ataxia
+∞
108.1
99
*
R27.0
ICD-10 Finland
Ataxia, unspecified
242.6
79.3
79
*
G11.8
ICD-10 Finland
Other hereditary ataxias
+∞
62.0
58
*
G11.4
ICD-10 Finland
Hereditary spastic paraplegia
+∞
42.4
40
*
Z31.5
ICD-10 Finland
Genetic counselling
9.6
31.7
67
81
N99
ICPC
Neurological disease other
28.8
27.6
37
14
N03AE01
ATC
clonazepam; systemic
7.3
23.4
58
90
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.1
22.7
76
173
N29
ICPC
Neurological sympt/complt other
14.0
21.1
36
28
3342A
ICD-9 Finland
Spinocerebellar disease, Primary cerebellar degeneration
+∞
21.0
20
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
81.0
20.9
23
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.4
20.0
63
133
M03BX01
ATC
baclofen; systemic
12.6
19.7
35
30
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.9
18.7
64
148
TAB00
NOMESCO Finland
Lumbar puncture
8.1
18.5
42
57
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
8.1
17.6
40
54
L28
ICPC
Limited function/disability (L)
3.3
16.9
97
353
R1250
NOMESCO Finland
Evaluation of functional capability
12.3
16.8
30
26
N28
ICPC
Limited function/disability (N)
14.2
16.7
28
21
R26.0
ICD-10 Finland
Ataxic gait
31.5
16.3
21
7
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
8.2
14.9
33
43
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
58.9
14.9
17
*
G11.00
ICD-10 Finland
Cerebellar dysplasia and aplasia
+∞
14.7
14
*
R42
ICD-10 Finland
Dizziness and giddiness
2.7
14.4
119
543
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
23.2
14.3
20
9
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.3
14.3
55
143
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
13.9
157
845
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
13.2
54
149
G11.18
ICD-10 Finland
Early-onset cerebellar ataxia
+∞
12.6
12
*
N03AX12
ATC
gabapentin; oral
2.8
12.4
85
345
3343A
ICD-9 Finland
Spinocerebellar disease, Other cerebellar ataxia
+∞
11.5
11
*
A28
ICPC
Limited function/disability NOS
2.7
11.4
87
373
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.9
11.3
31
56
R47.1
ICD-10 Finland
Dysarthria and anarthria
20.7
11.2
16
8
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.2
10.2
24
35
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.6
9.9
28
53
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.5
9.5
33
78
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.2
9.5
35
88
Z82.0
ICD-10 Finland
Family history of epilepsy and other diseases of the nervous system
102.2
9.5
10
*
3349X
ICD-9 Finland
Spinocerebellar disease, unspecified
+∞
9.4
9
*
N18
ICPC
Paralysis/weakness
8.6
9.2
19
23
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.0
9.1
36
97
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
8.8
80
376
SPAT1229
SPAT
Assessment of need for aid
3.1
8.6
46
158
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
8.5
62
258
7812A
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Abnormality of gait
91.8
8.4
9
*
G72.9
ICD-10 Finland
Myopathy, unspecified
13.1
8.4
14
11
G11
ICD-10 Finland
Hereditary ataxia
+∞
8.4
8
*
G11.02
ICD-10 Finland
Dysequilibrium syndrome
+∞
8.4
8
*
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
8.4
8
*
N06AA09
ATC
amitriptyline; systemic
2.8
8.1
52
201
G04BD04
ATC
oxybutynin; oral, transdermal
3.4
8.0
38
120
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
7.9
81
402
XA800
NOMESCO Finland
Neuropsychological investigation
4.1
7.5
28
72
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.4
7.5
35
109
G35
ICD-10 Finland
Multiple sclerosis
7.9
7.5
16
21
N05BA01
ATC
diazepam; systemic, rectal
2.4
7.3
66
307
G12.2
ICD-10 Finland
Motor neuron disease
+∞
7.3
7
*
ABD40
NOMESCO Finland
Implantation of spinal injection device
+∞
7.3
7
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.7
7.1
46
180
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.0
109
644
G04BD07
ATC
tolterodine; oral
3.5
6.9
31
94
R4130
NOMESCO Finland
Speech therapy
5.2
6.9
20
40
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
22.9
6.7
9
*
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.5
6.7
29
86
N04BB01
ATC
amantadine; oral
8.9
6.6
13
15
R1260
NOMESCO Finland
Evaluation of communicative skills
5.9
6.5
17
30
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
4.2
6.5
23
57
Z50.1
ICD-10 Finland
Other physical therapy
3.2
6.5
32
105
A06AD11
ATC
lactulose; oral
2.1
6.4
71
365
N06AB04
ATC
citalopram; systemic
2.0
6.3
86
482
G82.2
ICD-10 Finland
Paraplegia, unspecified
27.1
6.2
8
*
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
12.8
6.1
10
8
S82.6
ICD-10 Finland
Fracture of lateral malleolus
3.1
6.1
32
110
N03AF02
ATC
oxcarbazepine; oral
4.3
6.1
21
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
183
1093
2.12
13.18
2.4
2.1
u/l
242.1
310.1
0.25
171
1021
(3001186) Copper [Moles/volume] in Serum or Plasma
17
8
22.00
12.09
1.1
1.1
umol/l
15.8
16.0
—
17
8
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
20
7.19
9.33
1.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
208
1431
1.83
9.04
2.2
2.0
pmol/l
90.6
94.6
0.69
117
738
(3023183) Ammonium ion [Moles/volume] in Plasma
30
91
3.46
8.50
3.8
3.6
umol/l
29.5
35.4
1.01
25
78
(3019309) Folate [Moles/volume] in Red Blood Cells
112
669
1.89
7.38
1.7
1.7
nmol/l
1096.3
1184.7
0.44
92
501
(1761868) Lipid panel - Serum or Plasma
64
1174
0.47
7.35
2.8
3.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
31
4.97
6.98
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
64
3.56
6.65
1.3
2.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
16
37
4.44
6.54
1.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
59
292
2.17
6.51
1.7
3.0
g/l
66.6
66.3
0.13
53
266
(3016018) Differential panel - Cerebral spinal fluid
14
30
4.78
6.25
1.4
3.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
31
4.63
6.02
1.3
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
129
855
1.71
5.86
1.6
1.5
nmol/l
20.9
21.0
0.04
111
712
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
18
50
3.71
5.81
1.0
1.1
iu/ml
1.1
17.1
—
10
8
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
230
1785
1.58
5.45
6.9
7.7
mmol/l
1.2
1.2
0.46
207
1512
(3004588) Protein electrophoresis panel - Serum or Plasma
48
239
2.13
5.22
1.7
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
147
1040
1.61
5.08
4.2
3.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
37
3.87
4.85
1.6
2.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
39
3.67
4.52
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
54
301
1.90
4.32
4.6
3.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
142
1032
1.55
4.26
5.0
4.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
207
1631
1.49
4.23
6.2
7.1
mmol/l
1.2
1.2
0.38
186
1466
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
301
3402
0.66
4.04
4.7
4.4
mmol/l
1.4
1.4
0.79
283
3115
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
265
0.33
3.69
1.3
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
175
1366
1.46
3.60
2.7
2.4
nmol/l
73.1
76.2
0.74
156
1204
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
89
603
1.59
3.57
1.9
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
306
3423
0.68
3.57
4.7
4.5
mmol/l
4.5
4.6
0.60
285
3156
(4027681)
9
18
5.08
3.38
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
37
3.30
3.36
1.4
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
315
3488
0.69
3.26
5.1
5.0
mmol/l
2.7
2.7
0.15
287
3191
(3024561) Albumin [Mass/volume] in Serum or Plasma
194
1566
1.41
3.24
5.7
5.0
g/l
35.1
35.4
0.27
176
1459
(3044927) Protein electrophoresis panel - Urine
12
38
3.22
3.23
2.4
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
65
418
1.65
3.22
2.2
1.8
%
1.6
1.5
0.49
58
365
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
15
5.41
3.20
1.5
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
106
765
1.50
3.19
5.2
3.9
kg/l
1.0
1.0
0.24
16
103
(3019198) Lymphocytes [#/volume] in Blood
218
1804
1.40
3.12
6.1
6.3
e9/l
1.9
2.0
0.08
185
1584
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
296
3300
0.71
3.02
4.2
4.0
mmol/l
1.4
1.3
1.49
275
3007
(21494755) Public health laboratory ask at order entry panel
12
305
0.38
3.00
1.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
103
752
1.48
2.91
1.7
1.8
pmol/l
208333774.4
6441666.8
0.76
96
621
(3022217) INR in Platelet poor plasma by Coagulation assay
70
470
1.58
2.91
22.1
22.3
inr
1.0
1.4
—
7
65
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
22
4.15
2.89
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
22
4.15
2.89
1.6
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
54
341
1.66
2.87
4.5
8.0
mmol/l
1.4
1.4
0.02
47
325
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
102
746
1.47
2.86
1.3
1.2
u/ml
0.7
1.3
1.78
28
197
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
18
4.50
2.80
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
18
4.50
2.80
1.6
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
41
243
1.75
2.74
2.8
2.4
—
18.6
—
0
11
(3006315) Basophils [#/volume] in Blood
211
1769
1.36
2.66
6.1
6.3
e9/l
0.0
0.0
0.43
182
1519
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
25
127
2.02
2.66
1.9
2.3
ug/l
382.5
627.3
0.23
25
122
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
8
20
4.05
2.58
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
64
435
1.55
2.53
9.0
7.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
209
1761
1.34
2.51
6.1
6.2
e9/l
0.6
0.6
1.19
181
1509
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
300
3303
0.73
2.49
17.3
13.7
ml/min/173m2
81.9
80.0
0.67
247
2710
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
57
826
0.65
2.48
2.6
3.0
ug/l
0.7
0.8
0.39
38
553
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
61
414
1.55
2.43
4.3
9.1
kpa
5.3
5.1
0.72
56
397
(3027801) Oxygen [Partial pressure] in Arterial blood
61
414
1.55
2.43
4.2
9.1
kpa
11.1
11.9
0.62
56
399
(3022096) Basophils/100 leukocytes in Blood
194
1623
1.34
2.42
5.5
6.5
%
0.6
0.6
0.02
178
1505
(3013115) Eosinophils [#/volume] in Blood
215
1828
1.33
2.39
6.1
6.7
e9/l
0.2
0.2
0.07
187
1595
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
13
4.66
2.28
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
36
2.82
2.21
2.7
2.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
310
3377
0.74
2.21
5.0
4.6
mmol/l
6.0
6.0
0.31
278
3067
(3003396) Base excess in Arterial blood by calculation
60
415
1.51
2.21
4.3
9.1
mmol/l
1.1
1.1
0.06
44
329
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
19
3.72
2.16
1.0
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
146
1193
1.33
2.08
5.2
6.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
56
0.00
2.07
0.0
3.3
—
31.2
—
0
56
(3019069) Monocytes/100 leukocytes in Blood
196
1670
1.30
2.06
7.0
6.8
%
8.6
8.8
0.48
180
1558
(3021901) Oxygen saturation in Capillary blood
16
76
2.15
2.05
2.3
2.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
195
1662
1.30
2.04
6.2
6.4
%
2.7
2.8
0.30
181
1541
(3047181) Lactate [Moles/volume] in Blood
21
111
1.93
2.04
2.9
11.0
mmol/l
1.1
1.3
0.56
14
96
(3010813) Leukocytes [#/volume] in Blood
370
3913
0.71
2.04
27.5
22.1
e9/l
7.2
6.8
2.82
354
3792
(3000963) Hemoglobin [Mass/volume] in Blood
370
3913
0.71
2.04
27.7
22.2
g/l
132.7
135.6
3.13
359
3845
(3026361) Erythrocytes [#/volume] in Blood
370
3912
0.72
2.02
27.5
22.0
e12/l
4.4
4.5
1.30
353
3795
(3035941) MCH [Entitic mass]
370
3911
0.72
2.00
27.3
22.0
pg
30.1
30.3
1.81
359
3843
(3007461) Platelets [#/volume] in Blood
370
3910
0.72
1.99
27.3
22.0
e9/l
259.6
244.5
3.70
356
3803
(3024731) MCV [Entitic volume]
370
3910
0.72
1.99
27.4
22.0
fl
90.6
91.0
1.02
359
3843
(3013826) Glucose [Moles/volume] in Serum or Plasma
241
2120
1.29
1.96
5.9
5.4
mmol/l
6.9
6.7
0.55
226
1984
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
172
0.40
1.95
1.1
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
39
2.60
1.93
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
155
0.38
1.93
1.0
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
136
1.81
1.91
1.3
2.4
g/l
3.8
3.8
0.02
11
103
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
136
1.81
1.91
1.3
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
136
1.81
1.91
1.3
2.4
g/l
7.5
7.5
0.02
12
108
(3037121) Protein [Mass/volume] in Urine
24
136
1.81
1.91
3.0
3.3
g/l
0.6
0.3
—
6
57
(3003458) Phosphate [Moles/volume] in Serum or Plasma
66
481
1.43
1.89
7.2
7.0
mmol/l
1.1
1.1
0.83
61
443
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
112
892
1.34
1.88
2.3
2.1
mg/l
2.9
3.1
0.57
96
764
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
59
421
1.46
1.88
1.8
1.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
28
2.89
1.87
1.1
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
17
3.56
1.84
4.2
2.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
39
256
1.57
1.83
4.3
6.0
mmol/l
1.3
1.6
0.15
32
195
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
298
3235
0.77
1.83
6.7
6.0
mmol/mol
41.6
40.2
1.29
279
2989
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
12
4.20
1.83
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
12
4.20
1.83
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
48
331
1.50
1.81
5.6
4.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
268
2944
0.78
1.79
22.2
18.9
%
14.0
13.7
1.21
259
2880
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
147
1.74
1.78
1.8
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
91
1146
0.74
1.77
4.6
4.4
%
19.4
21.4
0.74
40
557
(3002030) Lymphocytes/100 leukocytes in Blood
197
1705
1.27
1.77
6.3
6.6
%
26.0
27.4
0.81
181
1587
(3013650) Neutrophils [#/volume] in Blood by Automated count
232
2049
1.27
1.76
7.7
10.0
e9/l
4.5
4.2
0.96
195
1778
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
306
0.54
1.75
1.4
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
60
436
1.43
1.75
1.9
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
24
2.95
1.73
2.0
2.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
13
3.88
1.72
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
13
3.88
1.72
1.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
111
1.84
1.71
1.4
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
48
0.00
1.70
0.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
147
0.40
1.67
1.2
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
19
3.19
1.66
1.7
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
255
1.53
1.64
1.6
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
128
1.76
1.63
1.3
2.5
g/l
2.7
3.1
0.97
12
105
(3019060) Gas panel - Arterial blood
36
240
1.54
1.60
4.0
6.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
85
1.91
1.57
1.5
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
193
1686
1.25
1.55
6.1
6.3
%
58.7
57.4
0.70
179
1574
(3000991) Gas panel - Venous blood
45
318
1.46
1.53
6.7
9.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
40
564
0.68
1.53
1.3
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
15
3.36
1.52
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
124
1.73
1.50
1.2
2.5
g/l
8.9
10.7
1.14
14
111
(3004616) Nuclear Ab [Presence] in Serum
9
37
2.46
1.48
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
133
1.69
1.45
2.0
1.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
51
374
1.41
1.44
4.7
9.7
%
93.9
95.5
0.43
46
361
(3005570) Glucose [Moles/volume] in Urine
9
39
2.33
1.43
2.3
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
81
1.88
1.41
2.5
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
39
273
1.47
1.41
4.5
5.8
kpa
5.3
5.1
0.78
39
251
(3003338) MCHC [Mass/volume]
275
2976
0.81
1.40
24.2
19.9
g/l
331.3
332.7
1.46
269
2956
(3018418) pH of Serum or Plasma
128
1078
1.26
1.40
4.2
4.2
ph
7.4
7.4
0.78
16
187
(3011397) Hemoglobin [Presence] in Urine by Test strip
97
790
1.29
1.39
5.2
3.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
24
151
1.62
1.37
3.2
2.7
—
—
—
0
0
(4035726)
20
317
0.61
1.33
1.5
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
277
2544
1.23
1.32
3.8
3.7
pmol/l
15.2
14.8
1.46
246
2273
(3000492) Spirometry study
22
340
0.63
1.32
1.5
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
56
425
1.36
1.30
1.8
2.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
300
3206
0.81
1.29
18.6
16.6
%
37.5
40.0
2.43
172
2281
(3022313) Gas panel - Capillary blood
30
203
1.51
1.28
4.2
6.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
25
2.42
1.24
10.7
2.2
%
14.3
13.3
—
6
25
(3008295) Osmolality of Serum or Plasma
8
37
2.18
1.22
1.8
1.8
mosm/kgh2o
272.5
278.9
—
8
26
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
19
2.65
1.22
1.0
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
42
561
0.72
1.20
1.2
1.3
iu/ml
38.8
37.9
0.02
11
180
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
33
232
1.46
1.19
1.8
1.7
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
65
1.87
1.14
1.2
1.2
—
1.1
—
0
5
(3045424) Erythrocytes [Presence] in Urine
10
51
1.98
1.12
2.1
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
51
1.98
1.12
1.9
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
96
1.69
1.11
1.4
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
48
366
1.35
1.11
5.1
4.9
mmol/l
1.6
1.7
0.08
43
287
(3017704) Immunofixation for Urine
5
21
2.40
1.09
1.0
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
39
517
0.73
1.08
1.2
1.3
u/ml
3.9
13.7
1.40
16
181
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
150
1319
1.20
1.07
4.0
3.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
100
845
1.23
1.06
2.4
2.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
106
1.63
1.04
3.5
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
187
1682
1.19
1.04
4.4
3.7
estimate
0.0
0.0
0.00
28
310
(3014271) Vancomycin [Susceptibility]
5
22
2.29
1.03
3.2
2.5
—
—
—
0
0
(3000012) Reticulocyte production index
5
22
2.29
1.03
1.4
2.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
34
2.07
1.03
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
358
3730
0.81
1.01
12.3
10.8
u/l
27.0
26.5
0.11
339
3596
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
48
1.89
1.01
1.9
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
64
784
0.79
1.00
1.8
2.1
mg/l
1.2
1.3
0.07
46
603
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
76
1.73
1.00
1.5
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
76
1.73
1.00
1.5
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
60
481
1.28
0.99
1.4
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
61
1.82
0.99
1.5
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
352
3671
0.82
0.98
18.2
13.9
—
—
—
0
0
(3026782) Osmolality of Urine
86
721
1.24
0.98
2.9
3.1
mosm/kgh2o
504.6
568.8
2.14
76
611
(3000850) Epithelial cells [#/volume] in Urine
89
749
1.23
0.98
2.7
2.8
e6/l
4.9
4.5
0.15
81
660
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
50
1.82
0.97
2.0
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
50
1.82
0.97
2.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
50
1.82
0.97
2.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
50
1.82
0.97
2.0
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
121
1053
1.20
0.96
3.6
3.2
mg/l
718.9
120.7
0.54
79
703
(3037467) Urinalysis macro (dipstick) panel - Urine
259
2406
1.18
0.96
5.4
4.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
292
2740
1.18
0.95
8.8
7.8
u/l
85.1
81.3
0.44
270
2558
(3044889) 12 lead EKG panel
229
2473
0.85
0.95
3.9
3.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
51
1.78
0.95
2.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
181
1636
1.18
0.93
4.0
4.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
32
237
1.38
0.90
3.8
2.7
e9/l
4.5
4.0
0.46
22
184
(3029937) Albumin [Presence] in Urine by Test strip
107
926
1.20
0.90
5.5
3.9
estimate
0.0
0.0
0.50
29
297
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
125
1413
0.84
0.89
4.8
5.0
ug/l
2.7
3.0
0.19
102
1266
(3044640) Blood type and Crossmatch panel - Blood
127
1118
1.19
0.89
2.4
2.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
23
161
1.45
0.88
1.0
1.1
—
34.0
—
0
5
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
41
318
1.32
0.87
2.8
2.4
ug/l
4.0
7.5
2.02
36
278
(36660697) Celiac disease serology panel - Serum
35
265
1.35
0.87
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
126
1113
1.18
0.84
4.3
4.0
mg/mmol
21.8
9.8
0.68
88
719
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
134
1190
1.18
0.84
4.7
3.5
u/l
30.6
33.5
0.53
127
1133
(40768804) Tissue Pathology biopsy report
121
1365
0.85
0.84
2.0
2.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
121
1.51
0.84
2.1
2.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
362
0.73
0.83
1.4
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
16
105
1.54
0.82
3.2
3.4
mmol/l
24.0
24.3
0.11
16
90
(3009261) Glucose [Presence] in Urine by Test strip
187
1708
1.16
0.82
4.6
3.8
estimate
0.0
0.0
0.00
28
297
(3037756) Immunofixation for Serum or Plasma
13
81
1.62
0.82
1.2
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
8
47
1.71
0.81
1.3
1.7
g/l
30.1
33.1
—
8
42
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
125
1108
1.18
0.80
3.3
2.6
u/l
48.5
57.4
2.94
118
1027
(1002224) Polysomnography panel
9
148
0.60
0.80
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
66
551
1.23
0.80
1.8
2.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.4
—
4.7
—
0
13
(40768441) Liver Pathology biopsy report
6
33
1.83
0.79
3.0
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
6
33
1.83
0.79
2.7
2.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
0
25
0.00
0.79
0.0
5.9
—
7.4
—
0
8
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.2
—
0.1
—
0
13
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
192
1.38
0.77
2.3
2.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
184
1687
1.15
0.76
5.7
5.1
estimate
0.0
0.0
0.00
32
305
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
339
3524
0.85
0.76
20.7
15.2
mg/l
28.0
24.0
1.10
277
2792
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
13
83
1.58
0.75
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
228
1.34
0.75
1.6
1.3
—
—
—
0
0
(3020891) Body temperature
19
133
1.45
0.75
4.8
3.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
3.2
1.5
g/l
0.8
1.0
—
5
24
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
25
2.01
0.73
2.0
1.5
—
—
—
0
0
(4024509)
5
25
2.01
0.73
2.6
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
126
1128
1.16
0.72
5.2
3.2
mmol/l
7.3
7.6
0.29
109
942
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
205
0.67
0.71
1.3
1.2
iu/ml
231.6
133.8
—
5
81
(3028626) Oxygen [Partial pressure] in Capillary blood
18
126
1.45
0.71
2.8
7.5
kpa
8.7
8.3
0.38
18
113
(3035637) Corticotropin [Mass/volume] in Plasma
7
41
1.72
0.70
1.1
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
35
276
1.29
0.69
2.4
3.8
mmol/l
1.2
1.2
0.27
28
238
(40761536) Microorganisms panel - Urine sediment
21
283
0.73
0.68
5.0
3.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
118
0.59
0.68
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
43
1.64
0.67
1.9
2.5
pg
32.0
33.2
—
7
43
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
28
1.79
0.66
1.0
1.5
u/l
49.2
25.5
—
5
23
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
202
1879
1.13
0.66
7.3
6.9
umol/l
12.5
12.0
0.15
191
1783
(40768806) Pleura Pathology biopsy report
7
44
1.60
0.65
1.4
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
82
933
0.85
0.63
1.9
1.7
mmol/l
1.4
1.4
0.11
70
782
(4010399)
33
262
1.28
0.63
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.4
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
63
1.60
0.62
1.0
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
30
1.67
0.61
1.2
1.2
u/l
47.0
175.7
—
5
18
(44813793)
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
72
1.54
0.59
1.2
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.2
—
0.8
—
0
8
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
35
1.72
0.58
1.3
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
159
1468
1.13
0.57
11.8
9.6
inr
1.2
1.3
0.11
40
411
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
16
115
1.41
0.57
4.4
7.3
mg/l
1.6
1.5
0.12
16
104
(21494890) Protein electrophoresis panel - 24 hour Urine
6
36
1.68
0.57
1.2
2.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
86
0.58
0.56
1.2
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
73
1.52
0.56
1.7
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
158
1460
1.13
0.56
3.0
2.7
ug/l
108.3
142.3
2.02
144
1343
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
1.0
1.2
pmol/l
141.3
565.9
—
6
32
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
282
0.77
0.54
1.7
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
143
1317
1.12
0.54
5.0
3.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
67
585
1.17
0.54
2.8
2.4
umol/l
11.4
13.0
0.99
56
541
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
79
701
1.15
0.52
4.8
3.9
ng/l
460.2
316.6
0.20
58
557
(3026493) Urate [Moles/volume] in Serum or Plasma
84
938
0.87
0.52
3.2
3.0
umol/l
10245.7
7296.7
0.17
72
806
(3013512) EKG study
115
1050
1.13
0.50
4.6
4.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
19
145
1.32
0.49
4.2
8.6
%
1.3
1.6
0.65
14
136
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
374
1.20
0.48
1.7
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
39
328
1.21
0.48
2.4
3.3
e9/l
65.2
70.8
0.53
34
256
(3004789) Transferrin [Mass/volume] in Serum or Plasma
61
535
1.16
0.47
2.9
2.4
g/l
2.2
2.3
0.45
55
493
(3017446) Testosterone [Moles/volume] in Serum or Plasma
25
309
0.80
0.47
2.5
2.3
nmol/l
15.9
13.3
0.39
17
280
(3027945) Reticulocytes/100 erythrocytes in Blood
51
441
1.18
0.47
2.4
3.5
%
1.7
1.8
1.01
44
398
(3027944) Amphetamines [Presence] in Urine
8
118
0.67
0.46
9.9
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
81
0.61
0.46
1.2
1.3
—
—
—
0
0
(4094501)
5
82
0.61
0.46
1.4
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
138
1.32
0.46
2.0
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
317
0.81
0.44
1.8
2.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
75
672
1.14
0.44
2.9
3.0
mmol/l
2.5
2.4
1.05
61
592
(3021589) Normoblasts [#/volume] in Blood
149
1592
0.90
0.44
11.2
10.1
e9/l
0.0
0.0
0.61
115
1288
(3011288) Drugs identified in Urine by Screen method
11
78
1.42
0.43
15.0
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
185
1.26
0.42
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
93
0.64
0.42
1.3
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
401
0.84
0.42
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
58
512
1.15
0.42
2.9
2.4
%
21.5
22.8
0.37
46
442
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
199
2093
0.91
0.42
2.7
3.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
58
1.39
0.41
1.1
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
16
0.00
0.41
0.0
4.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
16
0.00
0.41
0.0
4.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
17
0.00
0.40
0.0
6.5
—
35.0
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
17
0.00
0.40
0.0
16.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
34
1.48
0.40
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
102
0.68
0.40
1.4
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
104
0.67
0.40
4.9
5.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
3.5
—
66.7
—
0
19
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
14
181
0.77
0.38
3.4
4.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
68
1.33
0.38
3.1
2.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
44
1.37
0.34
1.2
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.5
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
18
145
1.25
0.34
3.1
8.7
%
0.8
0.9
0.33
13
136
(40760892) CBC W Ordered Manual Differential panel - Blood
69
757
0.90
0.34
3.7
5.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
45
1.34
0.34
1.5
1.6
ug/l
15.3
17.3
—
6
45
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
96
0.73
0.31
1.4
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
53
1.33
0.31
14.3
12.1
mmol/l
7.0
6.7
—
7
43
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
55
1.28
0.30
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
125
1180
1.08
0.29
2.9
3.3
mmol/l
2.4
2.3
0.74
104
1032
(3014576) Chloride [Moles/volume] in Serum or Plasma
51
461
1.12
0.28
5.7
7.7
mmol/l
105.0
104.2
0.46
51
452
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
103
1.27
0.28
1.8
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
63
1.27
0.28
9.6
2.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
117
0.76
0.27
8.9
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
119
0.75
0.27
8.9
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
120
0.75
0.27
8.9
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
321
3140
1.07
0.27
4.8
4.5
mu/l
1.9
2.3
0.54
289
2823
(3041096) Erythrocytes [Presence] in Urine by Automated
87
931
0.92
0.27
3.3
3.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
23
197
1.18
0.26
2.7
3.2
e6/l
0.2
0.2
0.00
23
189
(3000494) Fungus identified in Specimen by Culture
48
436
1.11
0.25
1.5
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
75
698
1.09
0.25
1.3
1.4
g/l
2.3
2.5
0.41
37
423
(3024928) Oxygen saturation in Venous blood
9
76
1.19
0.24
2.0
7.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
48
437
1.11
0.24
1.6
1.3
titre
778.7
391.5
0.58
15
89
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
126
0.79
0.24
1.7
5.8
%
88.0
89.0
—
10
121
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
77
1.17
0.24
1.4
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
77
1.17
0.24
1.1
1.4
—
—
—
0
0
(4146454)
5
38
1.32
0.23
2.2
2.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
168
0.83
0.23
1.1
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
48
439
1.10
0.23
4.1
4.5
%
30.8
31.7
0.26
34
288
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
10
0.00
0.21
0.0
9.6
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.3
—
2.8
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
9.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
9.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
154
1.18
0.21
1.1
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
104
0.77
0.21
3.6
3.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
12
0.00
0.21
0.0
3.3
—
104.7
—
0
12
(40765096) Chromosome analysis panel by Banding
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(44806420)
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
35
386
0.90
0.21
4.3
4.6
ug/l
4.5
39.8
1.08
30
331
(40760888) Immunoglobulin light chains.free panel - Serum
10
80
1.26
0.20
1.0
5.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
48
1.25
0.20
1.3
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
114
0.79
0.20
8.9
2.1
—
—
—
0
0
(4306422)
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
53
1.13
0.18
2.8
3.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
88
925
0.94
0.18
1.3
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
195
0.87
0.18
1.1
1.2
—
—
—
0
0
(4034850)
14
119
1.18
0.18
6.1
10.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
60
1.17
0.18
2.0
4.9
—
975.3
—
0
7
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
186
1.14
0.17
6.0
13.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
136
1408
0.95
0.17
5.3
3.8
ng/l
31.7
41.7
0.37
106
995
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
69
0.72
0.17
1.0
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
69
0.72
0.17
1.2
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
76
0.79
0.15
1.7
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
78
0.77
0.15
1.2
1.2
nmol/l
0.6
1.0
—
6
64
(3007566) Smooth muscle Ab [Titer] in Serum
12
102
1.18
0.15
1.3
1.2
—
58.3
—
0
6
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
102
1.18
0.15
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
102
1.18
0.15
1.1
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
29
265
1.10
0.15
4.2
4.8
%
0.1
0.1
—
7
79
(3002582) Erythrocytes [#/volume] in Urine
116
1119
1.05
0.15
3.9
3.4
e6/l
44.6
108.3
0.53
92
858
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
89
0.78
0.14
1.0
1.9
pmol/l
180.6
229.8
—
7
83
(3048689) Calprotectin [Mass/mass] in Stool
37
398
0.92
0.14
2.5
2.4
ug/g
147.6
132.6
0.16
24
317
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
103
1.17
0.14
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
103
1.17
0.14
1.1
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
97
0.82
0.14
1.3
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
361
3646
0.95
0.13
22.3
17.9
mmol/l
4.0
4.0
1.29
349
3537
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
267
1.09
0.13
3.1
2.8
ml/min/173m2
57.4
64.9
0.44
11
115
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
113
1.15
0.13
1.1
1.8
—
192.0
—
0
5
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
113
1.15
0.13
1.8
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
105
1014
1.05
0.13
3.8
3.3
e6/l
0.4
0.5
0.50
86
751
(3022145) Colonoscopy Study observation
38
406
0.93
0.13
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
56
532
1.06
0.12
1.9
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
94
910
1.04
0.11
5.4
7.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
66
634
1.05
0.10
3.2
2.8
e6/l
1.0
1.0
0.01
43
364
(3021440) Promyelocytes/100 leukocytes in Blood
30
281
1.07
0.10
4.0
4.7
%
0.0
0.2
—
7
94
(36304419) Bacteria [Presence] in Urine
101
982
1.04
0.09
3.8
3.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
361
3637
0.96
0.09
22.3
17.7
mmol/l
139.5
139.7
0.41
350
3528
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
36
380
0.94
0.09
3.6
3.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
124
0.88
0.09
1.8
2.1
mg/l
1.7
3.7
—
5
95
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
58
1.03
0.08
1.5
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
64
0.78
0.08
2.8
6.7
%
78.4
62.8
—
5
64
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
117
1.11
0.08
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
6
70
0.86
0.07
1.8
1.5
—
99.3
—
0
12
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
72
0.83
0.07
1.5
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
78
1.03
0.07
1.8
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
94
0.85
0.06
8.8
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
141
0.92
0.05
2.8
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
231
0.95
0.04
1.5
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
232
2302
1.02
0.04
4.6
3.3
u/l
56.3
48.9
0.26
215
2143
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
101
1.09
0.04
1.2
1.1
—
15.8
—
0
12
(3013707) Erythrocyte sedimentation rate by Westergren method
260
2615
0.99
0.03
4.6
4.1
mm/h
12.7
12.5
0.05
240
2374
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
108
0.92
0.03
1.8
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
217
0.97
0.01
4.0
2.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
31
303
1.02
0.01
4.0
4.5
%
1.1
1.0
—
8
103
(3002256) Pathology report gross observation
44
433
1.02
0.01
1.4
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
235
0.98
0.00
1.4
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
113
0.97
0.00
2.8
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
45
446
1.01
0.00
5.8
3.2
umol/l
8.1
9.5
0.25
38
397
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
11
112
0.98
0.00
3.5
2.5
ug/min
232.0
89.8
—
6
63
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
352
0.99
0.00
3.5
2.5
u/l
31.6
35.4
0.41
29
294
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
45
452
1.00
0.00
1.7
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
128
1279
1.00
0.00
4.5
4.0
e6/l
105.8
119.1
0.12
99
908
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
112
1117
1.00
0.00
2.8
3.3
ng/l
1708.4
1427.3
0.13
91
952
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
61
605
1.01
0.00
3.5
3.0
e6/l
4.4
1.9
0.47
39
339
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
6.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
56
0.89
0.00
8.4
3.7
%
8.2
1.1
—
5
48
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.0
—
134.3
—
0
9
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
6.8
—
0
9
(3014051) Protein [Presence] in Urine by Test strip
7
76
0.92
0.00
2.0
2.1
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
3.6
—
0
9
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
91
0.99
0.00
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
4.8
—
150.7
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
27.4
—
0.5
—
0
7
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
31.3
—
0
6
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
93
0.97
0.00
1.2
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
1.2
—
0
5
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
159.0
—
0
5
(3006598) pH of Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
49
1.02
0.00
1.0
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
85
0.94
0.00
1.5
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
79
1.01
0.00
1.4
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
27
270
1.00
0.00
4.3
4.6
%
1.3
0.4
—
6
72
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
93.7
—
0
6
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HERATAXIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HERATAXIA | 2.78 [2.33, 3.31] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.092 |
During the follow-up period (1.1.1998 — 31.12.2019), 489 out of 1385 females with G6_HERATAXIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HERATAXIA | 2.804 [2.44, 3.23] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.028 |
During the follow-up period (1.1.1998 — 31.12.2019), 747 out of 1691 males with G6_HERATAXIA died.
Mortality risk
Mortality risk for people of age
years, who have G6_HERATAXIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.192% | 0.608% |
| 5 | 1.332% | 3.537% |
| 10 | 3.554% | 8.971% |
| 15 | 6.657% | 16.761% |
| 20 | 11.625% | 27.207% |
Relationships between endpoints
↥Index endpoint: G6_HERATAXIA – Hereditary ataxia
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data